RHYTHM director granted RSUs and options
RHYTHM PHARMACEUTICALS, INC. director Kimberly J. Popovits received equity-based compensation on April 1, 2026.
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS, INC. director Kimberly J. Popovits received equity-based compensation on April 1, 2026. She was granted 6,808 Restricted Stock Units, each representing a right to receive one share of common stock.
The RSUs vest in three equal installments of 33% on April 1, 2027, April 1, 2028, and April 1, 2029, provided she continues in service. She was also granted 10,257 stock options with an exercise price of $88.12 per share, vesting in three substantially equal annual installments and expiring on March 31, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 17,065 shares
Grant/Award
2 txns
Insider
Popovits Kimberly J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 6,808 | $0.00 | $0.00 |
| Grant/Award | Stock Options (Right to Buy) | 10,257 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 6,808 contracts (Direct);
Stock Options (Right to Buy) — 10,257 contracts (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029. The restricted stock units have no expiration date.
- F3. The stock options were granted on April 1, 2026. The options vest and become exercisable in three substantially equal annual installments subject to the Reporting Person continuing in service through each such vesting date.
Key Figures
Restricted Stock Units granted: 6,808 units
Stock options granted: 10,257 options
Option exercise price: $88.12 per share
+3 more
6 metrics
Restricted Stock Units granted
6,808 units
Awarded on April 1, 2026; vest in three 33% tranches 2027–2029
Stock options granted
10,257 options
Granted April 1, 2026 as director equity compensation
Option exercise price
$88.12 per share
Strike price for 10,257 stock options
Options expiration date
March 31, 2036
Final exercise date for granted stock options
RSU holdings after grant
6,808 RSUs
Total RSUs directly held following April 1, 2026 transaction
Option holdings after grant
10,257 options
Total stock options directly held following April 1, 2026 grant
Key Terms
Restricted Stock Units, stock options, vest, exercise price, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock options financial
"The stock options were granted on April 1, 2026."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vest financial
"The restricted stock units will vest as to 33% of the total shares on each of April 1, 2027, April 1, 2028, April 1, 2029."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "88.1200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-03-31T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kimberly J. Popovits receive in this RYTM Form 4 filing?
Kimberly J. Popovits received equity compensation consisting of 6,808 Restricted Stock Units and 10,257 stock options. These awards give her potential future ownership of RHYTHM PHARMACEUTICALS common stock, subject to vesting conditions and continued service on the company’s board.
How do the 6,808 Restricted Stock Units for RYTM vest?
The 6,808 Restricted Stock Units vest in three installments of 33% each on April 1, 2027, April 1, 2028, and April 1, 2029. Vesting requires Kimberly J. Popovits to continue in service through each stated vesting date.
What are the key terms of the 10,257 RYTM stock options granted?
Kimberly J. Popovits was granted 10,257 stock options with an exercise price of $88.12 per share. These options vest in three substantially equal annual installments and expire on March 31, 2036, contingent on her continued service with the company.
Does this RYTM Form 4 show open-market buying or selling?
No open-market buying or selling appears; the filing reports equity awards. The transactions are coded as grants (code A), reflecting compensation-related acquisitions of Restricted Stock Units and stock options, rather than discretionary market purchases or sales of existing RHYTHM PHARMACEUTICALS shares.
How many RHYTHM PHARMACEUTICALS RSUs does Kimberly Popovits hold after this grant?
After the transaction, Kimberly J. Popovits holds 6,808 Restricted Stock Units directly, according to the Form 4. Each unit represents a contingent right to receive one share of RHYTHM PHARMACEUTICALS common stock once the applicable vesting conditions are satisfied.
What is the significance of the March 31, 2036 expiration date for RYTM options?
The March 31, 2036 expiration date marks the last day the 10,257 stock options can be exercised at $88.12 per share. After that date, any unexercised options lapse, so value realization depends on future stock price and vesting completion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
